market access teams
5.15.2013 Health Economics and Outcomes Research (HEOR)
Health Outcomes Liaisons and Payers Talk Health Economics
By Nicole May,
Research Analyst
The burden of proving drugs’ cost-effectiveness data falls in part to health outcomes liaisons (HOLs) who work between pharmaceutical companies and payers to get their company’s drugs onto formularies. HOLs...
2.5.2013 Market Access
I want THAT price: Understanding the Rationale Behind International Price Referencing
Growing up, siblings have an unspoken rule that if one received something or was allowed to do something that another wasn’t, instantly, life became “unfair” for the other party. The smaller the age differential between the siblings, the more unfair the...
9.20.2012 Managed Care Liaison / HOL
Moving Toward Health Outcomes Liaisons: Comparison of MSL and HOL Compensation Reflects an Industry Shift
Traditionally, health outcomes liaisons (HOLs) and medical science liaisons (MSLs) represent two different areas of expertise. Both jobs serve an important role: to provide an educational connection between industry leaders and key stakeholders. The former serves...
8.1.2012 Account Strategy for Government
Understand Payer Groups’ Needs to Secure Reimbursement
Before US managed markets teams approach payers, they need to understand the different payer groups. All groups — Medicare and Medicaid, insurance companies, specialty pharmacies, hospitals, etc. — share the same fundamental function: to sift through the many...
7.30.2012 Health Economics and Outcomes Research (HEOR)
When to Use Patient-Reported Outcomes
Companies are increasingly turning to patient-reported outcomes (PROs) as payers look for additional outcomes data when making reimbursement decisions. Our recent reports, “Market Access Management: Building Teams that Deliver Value to Payers” and “Health...
7.26.2012 Managed Care Liaison / HOL
Health Outcomes Liaisons Are an Important Communication Channel with Payers
As payer relationships become more important than ever, many companies are working hard to build and support teams that can communicate pharmacoeconomic benefits to payers. The members on these teams, often called outcomes liaisons or health outcomes liaisons (HOLs),...
7.9.2012 Health Economics and Outcomes Research (HEOR)
New Data: 29 Percent of Companies House HEOR within Medical Affairs
Health economics and outcomes research is often more scientifically focused than other market access-related functions. As a result, some companies have separated HEOR from pricing and reimbursement. Figure 1 below shows that 29 percent of companies now house...
6.7.2012 Account Strategy for Payer Organizations
Managed Care Account Managers: Build a Strong Payer Narrative for New Products
By Michelle Vitko,
Senior Research Analyst
When companies first approach payer organizations with information about a new product, it is important that managed markets account managers convey why payers need their product. Account managers must have...
4.30.2012 Managed Care Liaison / HOL
Health Outcomes Liaisons Spend Most Time Preparing to Present Health Economics Data
By Michelle Vitko,
Senior Research Analyst
Preparing to present data to managed care stakeholders is often health outcomes liaisons' (HOLs) most time-intensive activity. While the exact breakdown of time investment varies from company to company, most...
2.20.2012 Health Economics and Outcomes Research (HEOR)
Communicating the Value of Innovation through Health Economics Analysis
By Shaylyn Pike,Senior Research Analyst
Once upon a time, a brand team's quest ended at marketing approval; revenues would take care of themselves. Fast forward 20 years, and the industry faces a much more challenging road to brand success. Receiving...







